financetom
Business
financetom
/
Business
/
Apple asks US appeals court to reverse Apple Watch import ban
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apple asks US appeals court to reverse Apple Watch import ban
Apr 5, 2024 3:38 PM

(Reuters) - Apple ( AAPL ) urged a U.S. appeals court on Friday to overturn a U.S. trade tribunal's decision to ban imports of some Apple Watches in a patent dispute with medical-monitoring technology company Masimo ( MASI ).

Apple ( AAPL ) told the U.S. Court of Appeals for the Federal Circuit that the U.S. International Trade Commission's decision was based on a "series of substantively defective patent rulings," and that Masimo ( MASI ) failed to show it had invested in making competing U.S. products that would justify the order.

Representatives for Apple ( AAPL ) and Masimo ( MASI ) did not immediately respond to requests for comment on the filing.

Irvine, California-based Masimo ( MASI ) has accused Apple ( AAPL ) of hiring away its employees and stealing its pulse oximetry technology after discussing a potential collaboration. Apple ( AAPL ) first introduced pulse oximetry to its Series 6 Apple Watches in 2020.

Masimo ( MASI ) convinced the ITC on Dec. 26 to block imports of Apple's ( AAPL ) latest-edition Series 9 and Ultra 2 smartwatches after finding that their technology for reading blood-oxygen levels infringed Masimo's ( MASI ) patents.

Apple ( AAPL ) temporarily resumed sales of the watches the next day after persuading the Federal Circuit to pause the ban. The appeals court reinstated the ban in January, leading Apple ( AAPL ) to remove pulse oximetry capabilities from watches sold during the appeal, which Apple ( AAPL ) has said could last at least a year.

U.S. Customs and Border Protection separately determined in January that redesigned versions of the watches did not violate Masimo's ( MASI ) rights and would not be not subject to the ban. Masimo ( MASI ) said in a court filing that the watches "definitively do not contain pulse oximetry functionality."

Apple ( AAPL ) told the Federal Circuit on Friday that the ban could not stand because a Masimo ( MASI ) wearable covered by the patents was "purely hypothetical" when it filed its ITC complaint in 2021.

The tech giant also argued that Masimo's ( MASI ) patents were invalid and that its watches did not infringe them.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Triumph Financial Insider Sold Shares Worth $632,100, According to a Recent SEC Filing
Triumph Financial Insider Sold Shares Worth $632,100, According to a Recent SEC Filing
Aug 20, 2024
04:12 PM EDT, 08/20/2024 (MT Newswires) -- Aaron P Graft, Director, President & CEO, on August 16, 2024, sold 7,500 shares in Triumph Financial ( TFIN ) for $632,100. Following the Form 4 filing with the SEC, Graft has control over a total of 171,021 shares of the company, with 167,706 shares held directly and 3,315 controlled indirectly. SEC Filing:...
Astera Labs Insider Sold Shares Worth $581,508, According to a Recent SEC Filing
Astera Labs Insider Sold Shares Worth $581,508, According to a Recent SEC Filing
Aug 20, 2024
04:08 PM EDT, 08/20/2024 (MT Newswires) -- Michael Truett Tate, Chief Financial Officer, on August 16, 2024, sold 13,915 shares in Astera Labs ( ALAB ) for $581,508. Following the Form 4 filing with the SEC, Tate has control over a total of 2,206,016 shares of the company, with 1,326,908 shares held directly and 879,108 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629724000023/xslF345X03/wk-form4_1724184190.xml...
--Keysight Technologies Guides For Q4 EPS of $1.53-$1.59 on Revenue of $1.245-$1.265 Billion, vs CIQ Analyst Consensus of $1.54/Share on Revenue of $1.25 Billion
--Keysight Technologies Guides For Q4 EPS of $1.53-$1.59 on Revenue of $1.245-$1.265 Billion, vs CIQ Analyst Consensus of $1.54/Share on Revenue of $1.25 Billion
Aug 20, 2024
04:06 PM EDT, 08/20/2024 (MT Newswires) -- Price: 145.00, Change: +6.42, Percent Change: +4.63 ...
--Nicolet Bankshares Keeps Quarterly Dividend at $0.28 a Share, Payable Sept. 16 to Shareholders of Record Sept. 3
--Nicolet Bankshares Keeps Quarterly Dividend at $0.28 a Share, Payable Sept. 16 to Shareholders of Record Sept. 3
Aug 20, 2024
04:06 PM EDT, 08/20/2024 (MT Newswires) -- Price: 92.61, Change: +0.01, Percent Change: +0.01 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved